The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Effect of Amiodarone and Sotalol on Ventricular Defibrillation Threshold: The Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) Trial
Open accessAbstract
Background— Many patients with implanted cardioverter defibrillators (ICDs) receive adjunctive antiarrhythmic drug therapy, most commonly amiodarone or sotalol. The effects of these drugs on defibrillation energy requirements have not been previously assessed in a randomized controlled trial. Methods and Results— The Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients (OPTIC) trial was a randomized clinical trial evaluating the efficacy of amiodarone plus β-blocker and sotalol versus β-blocker alone for reduction of ICD shocks. Within OPTIC, a prospectively designed substudy evaluated the effects of the 3 treatment arms on defibrillation energy requirements. Defibrillation thresholds (DFTs) were measured (binary step-down protocol) at baseline and again after 8 to 12 weeks of therapy in 94 patients, of whom 29 were randomized to receive β-blocker therapy (control group), 35 to amiodarone plus β-blocker, and 30 to sotalol. In the control group, the mean DFT decreased from 8.77±5.15 J at baseline to 7.13±3.43 J ( P =0.027); in the amiodarone group, DFT increased from 8.53±4.29 to 9.82±5.84 J ( P =0.091). In the sotalol group, DFT decreased from 8.09±4.81 to 7.20±5.30 J ( P =0.21). DFT changes in the β-blocker and the amiodarone group were significantly different ( P =0.006). In all patients, adequate safety margins for defibrillation were maintained. No clinical variable predicted baseline DFT or changes in DFT on therapy. Conclusion— Although amiodarone increased DFT, the effect size with modern ICD systems is very small. Therefore, DFT reassessment after the institution of antiarrhythmic drug therapy with amiodarone or sotalol is not routinely required.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Data on the impact of antiarrhythmic drugs, used for atrial and ventricular arrhythmias, as well, on the defibrillation threshold are variable, but 1 randomized study 76 has suggested that amiodarone may increase, whereas sotalol and β-blockers decrease, the defibrillation threshold.”
From Managing with pacemakers and implantable cardioverter defibrillators (2013) · cites this paper as [76]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moss, A. J., Zaręba, W., Hall, W. J., Klein, H., Wilber, D. J., Cannom, D. S., Daubert, J. P., Higgins, S. L., Brown, M. W., & Andrews, M. L. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013474 · Cited by 6,885
Amiodarone or an Implantable Cardioverter–Defibrillator for Congestive Heart Failure
Bardy, G. H., Lee, K. L., Mark, D. B., Poole, J. E., Packer, D. L., Boineau, R., Domanski, M., Troutman, C., Anderson, J., Johnson, G., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043399 · Cited by 6,552
Prophylactic Defibrillator Implantation in Patients with Nonischemic Dilated Cardiomyopathy
Kadish, A. H., Dyer, A. R., Daubert, J. P., Quigg, R. J., Estes, N. A. M., Anderson, K. P., Calkins, H. G., Hoch, D., Goldberger, J. J., Shalaby, A. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033088 · Cited by 2,078
Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials
Connolly, S. J. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2476 · Cited by 1,138
Self-citationConnolly, S. J. (2006) · JAMA · doi:10.1001/jama.295.2.165 · Cited by 788
Self-citationDesai, A. S., Fang, J. C., Maisel, W. H., & Baughman, K. L. (2004) · JAMA · doi:10.1001/jama.292.23.2874 · Cited by 403
Russo, A. M., Sauer, W. H., Gerstenfeld, E. P., Hsia, H. H., Lin, D., Cooper, J. M., Dixit, S., Verdino, R. J., Nayak, H. M., Callans, D. J., et al. (2005) · Heart Rhythm · doi:10.1016/j.hrthm.2005.01.015 · Cited by 191
Epstein, A. E., Ellenbogen, K. A., Kirk, K. A., Kay, G. N., Dailey, S. M., & Plumb, V. J. (1992) · Circulation · doi:10.1161/01.cir.86.4.1206 · Cited by 174
Effects of chronic amiodarone therapy on defibrillation threshold
Jung, W., MANZ, M., Pizzulli, L., Pfeiffer, D., & Lüderitz, B. (1992) · The American Journal of Cardiology · doi:10.1016/0002-9149(92)90354-2 · Cited by 138
Efficacy and Temporal Stability of Reduced Safety Margins for Ventricular Defibrillation
Gold, M. R., Higgins, S. L., Klein, R. C., Gilliam, F. R., Kopelman, H. A., Hessen, S. E., PAYNE, J. P., Strickberger, S. A., Breiter, D. J., & Hahn, S. J. (2002) · Circulation · doi:10.1161/01.cir.0000015508.59749.f5 · Cited by 136
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–178 of 178
Management of Pace-Terminated Ventricular Arrhythmias
Pokorney, S. D., & Al‐Khatib, S. M. (2015) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2015.05.009 · Cited by 3
Malik, A. H., & Aronow, W. S. (2019) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000928 · Cited by 3
Predictors of Transthoracic Impedance in Patients Who Underwent Elective Electrical Cardioversion
Redel‐Traub, G., Elnabawi, Y. A., Gurel, K., Sudesh, S., Rosenbaum, H. R., Dizon, J. M., BIVIANO, A. B., Rubin, G. A., Wan, E. Y., Garan, H., et al. (2023) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2023.11.040 · Cited by 3
The Role of Defibrillation Testing
Amit, G., & Healey, J. S. (2015) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2015.05.015 · Cited by 3
Bradfield, J. S., Tung, R. H., Boyle, N. G., & Shivkumar, K. (2011) · Heart Failure Reviews · doi:10.1007/s10741-011-9241-7 · Cited by 3
Defibrillation Testing: The Need for a Definitive Trial
Duray, G. Z., & Hohnloser, S. H. (2009) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2009.01620.x · Cited by 3
Self-citationPacing and Defibrillation: Clinically Relevant Basics for Practice
Bunch, T. J., Hayes, D. L., Swerdlow, C. D., Asirvatham, S. J., & Friedman, P. A. (2012) · doi:10.1002/9781118483923.ch1 · Cited by 3
Decompensated Heart Failure With Ventricular Arrhythmia: How Useful Is VT Ablation?
Dimitropoulos, G., Leventogiannis, G., & de Bono, J. P. (2018) · Current Heart Failure Reports · doi:10.1007/s11897-018-0395-7 · Cited by 2
Insights on arrhythmia termination and type 2 breaks after ICD therapy delivery
Gagno, G., & Zoppo, F. (2020) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14030 · Cited by 2
Ist die intraoperative ICD-Testung noch nötig?
Mewis, C., Neuberger, H., & Buob, A. (2010) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-010-0080-3 · Cited by 2
Epicardial Ablation of VT in Patients with Nonischemic LV Cardiomyopathy
Hutchinson, M. D., & Marchlinski, F. E. (2010) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2009.11.007 · Cited by 2
Chevalier, P., Durand‐Dubief, A., Piqueras, E., Pineau, J., Rivard, L., Morel, É., Bui-xan, B., & Timour, Q. (2007) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318150d3f5 · Cited by 2
Köbe, J., Reinke, F., Dechering, D. G., BREITHARDT, G. E., & Eckardt, L. (2011) · Clinical Research in Cardiology · doi:10.1007/s00392-011-0379-z · Cited by 2
Drug-implantable cardioverter–defibrillator interactions
Beadle, R. M., Williams, L. K., & Lim, H. S. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.114 · Cited by 2
Bänsch, D., Schneider, R., Akın, İ., & Nienaber, C. A. (2012) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-012-0171-4 · Cited by 2
Iijima, K., Chinushi, M., Saitoh, O., Hasegawa, K., Sonoda, K., Yagihara, N., Sato, A., Izumi, D., Watanabe, H., Furushima, H., et al. (2015) · Internal Medicine · doi:10.2169/internalmedicine.54.3113 · Cited by 2
Approach to Arrhythmia in Heart Failure
Gaïta, F., Anselmino, M., & Matta, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-45237-1_12 · Cited by 2
Rhythm control in left ventricular assist device patients: should we consider abandoning amiodarone?
Kapelios, C. J., Tsamatsoulis, M., & Charitos, C. (2017) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2017.09.005 · Cited by 2
The Saga of Defibrillation Testing: When Less Is More
Gleva, M. J., Robinson, M., & Poole, J. E. (2018) · Current Cardiology Reports · doi:10.1007/s11886-018-0987-6 · Cited by 2
Results of Recent Studies in Catheter Ablation of Ventricular Tachycardias
Arya, A., Piorkowski, C., Kircher, S., Sommer, P., Bollmann, A., Gaspar, T., & Hindricks, G. (2009) · Herz · doi:10.1007/s00059-009-3298-2 · Cited by 2
Reiffel, J. A. (2007) · Current Cardiology Reports · doi:10.1007/bf02938365 · Cited by 2
Unresolved Issues in Implantable Cardioverter-Defibrillator Therapy
Mason, P. K., & Dimarco, J. (2008) · Cardiology Clinics · doi:10.1016/j.ccl.2008.03.008 · Cited by 2
Follow-Up of the Patient with an Implanted Cardiac Defibrillator
Abate, E. G., & Kusumoto, F. M. (2007) · Springer eBooks · doi:10.1007/978-0-387-72763-9_20 · Cited by 2
Morin, D. P., Kaufman, E. S., Campbell, K. B., Epstein, A. E., Goldberger, Z. D., Görenek, B., Hendriks, J., Kannankeril, P. J., Tamirisa, K. P., Valdés, S. O., et al. (2026) · Heart Rhythm · doi:10.1016/j.hrthm.2026.07.012 · Cited by 1
KARTAL, Y., Yavuzgil, O., BOZOGLU, M., Alp, A., Can, L. H., & Hasdemir, C. (2012) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2011.03326.x · Cited by 1
Defibrillation Threshold Testing
Cuoco, F. A., & Gold, M. R. (2012) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2012.02.003 · Cited by 1
Sato, A., Chinushi, M., Iijima, K., Watanabe, H., Izumi, D., Furushima, H., Sonoda, K., Hasegawa, K., Yagihara, N., & Aizawa, Y. (2011) · Internal Medicine · doi:10.2169/internalmedicine.50.5792 · Cited by 1
Glikson, M., Luria, D. M., Gurevitz, O. T., & Friedman, P. A. (2008) · Springer eBooks · doi:10.1007/978-1-84628-854-8_56 · Cited by 1
Contemporary management of ventricular arrhythmias in heart failure.
Kariki, O. K., Georgopoulos, M., Katsillis, N., Chatziantoniou, A., Koskina, S., Zygouri, A., Saplaouras, A., Bazoukis, G., Gkouziouta, A., Vlachos, K. G., et al. (2023) · PubMed Central · Cited by 1
An intuitive method to reduce the defibrillation threshold: a case report
Chaudry, H. A., & Maskoun, W. (2023) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytad577 · Cited by 1
Amiodarone in shockable cardiac arrest: lights and shadows
Currao, A., & Savastano, S. (2025) · Resuscitation · doi:10.1016/j.resuscitation.2025.110568 · Cited by 1
Defibrillator Threshold Testing
Zaqqa, M. (2013) · InTech eBooks · doi:10.5772/52594 · Cited by 1
Beyond Sudden Death Prevention: Minimizing ICD Shocks and Morbidity, and Optimizing Efficacy
Nof, E., Glikson, M., Luria, D. M., Gard, J. J., & Friedman, P. A. (2013) · Springer eBooks · doi:10.1007/978-1-4471-4978-1_40 · Cited by 1
WITHDRAWN Ventricular Arrhythmias in Non-ischemic Cardiomyopathy
Chung, F., Lin, C., Lin, Y., Chang, S., Lo, L., Hu, Y., Tuan, T., Chao, T., Liao, J., Chang, Y., et al. (2017) · Journal of Arrhythmia · doi:10.1016/j.joa.2017.08.003 · Cited by 1
Nakao, Y., Suenari, K., Yamashiro, K., Nakagawa, H., & Shiode, N. (2020) · BMC Cardiovascular Disorders · doi:10.1186/s12872-020-01405-4 · Cited by 1
Establishing a Standard for Peri-operative ICD Education : A Demonstration Project
Kirian, K. (2012) · ProQuest Demo Repository · Cited by 1
Colella, A., Giaccardi, M., Sabatini, A., Zuppiroli, A., & Franco, G. (2011) · InTech eBooks · doi:10.5772/22503
Atwater, B. D., & Daubert, J. P. (2010) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2010.01731.x · Cited by 1
SCHRICKEL, J. W., Beiert, T., & Andrié, R. (2021) · Elsevier eBooks · doi:10.1016/b978-3-437-23834-5.00013-x · Cited by 1
Bunch, T. J., Kapa, S., Hayes, D. L., Swerdlow, C. D., Asirvatham, S. J., & Friedman, P. A. (2021) · doi:10.1002/9781119264002.ch1 · Cited by 1
Tod während der Versorgung mit einem implantierbaren Kardioverter-/Defibrillator-System
Albalooshi, Y. M., Doberentz, E., & Madea, B. (2010) · Rechtsmedizin · doi:10.1007/s00194-010-0680-6
Clinical Role of Antiarrhythmic Drugs in the Prevention of Sudden Death
Lee, H.-C., & Huang, K. T. L. (2013) · Springer eBooks · doi:10.1007/978-1-4471-4978-1_33
Troubleshooting: Interpreting Diagnostic Information to Ensure Appropriate Function
Swerdlow, C. D., Friedman, P. A., Asirvatham, S. J., & Hayes, D. L. (2012) · doi:10.1002/9781118483923.ch10
Preventing Implantable Cardioverter Defibrillator Shocks Improves Survival
Winner, M. W., & Hummel, J. D. (2012) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2012.02.005
Seguimiento de los pacientes portadores de desfibrilador automático implantable
Álvarez, M., Tercedor, L., Almansa, I., & Algarra, M. (2008) · Revista Española de Cardiología Suplementos · doi:10.1016/s1131-3587(08)73535-0
Reducing ICD Shocks for Ventricular Arrhythmias
Schoenhard, J. A., & Zei, P. C. (2011) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2011.05.013
Clinical evidence of the role of edoxaban in anticoagulation
Fortuny, E., & Zamorano, J. L. (2012) · Clinical Investigation · doi:10.4155/cli.11.181
Goulart, E. T. V., de Vasconcelos, J. T. M., Filho, S. D. S. G., Barcellos, C. M. B., da Silva, E. L., Fragata, C. D. S., Martins, L. C. B., & Mingireanov, R. (2007) · DOAJ (DOAJ: Directory of Open Access Journals)
Antiarrhythmic Drugs and Management of Ventricular Arrhythmias
Schleifer, J. W., & Srivathsan, K. S. (2015) · Springer eBooks · doi:10.1007/978-3-319-15961-4_52
Atrial Fibrillation in Patients with Implantable
Sakhuja, R., Shah, A. J., Keebler, M., & Thakur, R. K. (2009)
Threshold Testing Who Doesn't Get It?
Cuoco, F. A., & Gold, M. R. (2012)
Droogan, C. J., Patel, C., Yan, G., & Kowey, P. R. (2011)
Krupa, W., Sielski, S., Dobosiewicz, R., Lackowski, J., Kalarus, Z. F., Filipecki, A., Köbe, J., Kempa, M., & Kubica, J. (2014)
Critical analysis of ineffective post implantation implantable cardioverter-defibrillator-testing
Roos, M., Geller, J. C., & Ohlow, M. (2017) · World Journal of Cardiology · doi:10.4330/wjc.v9.i2.167
Implantable cardioverter‐defibrillator testing in pediatric and congenital heart disease
Stephenson, E. A., & Berul, C. I. (2017) · doi:10.1002/9781119333050.ch7
Chauveau, S., Dulac, A., Sebbag, L., Morel, É., & Chevalier, P. (2017) · Clinical Case Reports · doi:10.1002/ccr3.968
Considerations for Novel or Alternative Lead Placement
AKOUM, N. W., & Hermsen, J. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40126-5.00009-4
How to Perform Defibrillation Threshold Testing
Brodt, C. R., & Perez, M. V. (2017) · doi:10.1002/9781118820674.ch14
Therapie von tachykarden Herzrhythmusstörungen
SCHRICKEL, J. W., & Andrié, R. (2018) · Elsevier eBooks · doi:10.1016/b978-3-437-24950-1.00012-3
Unusual case of late dislodgment of a superior vena cava coil
Glotzer, T. V., Shah, M., Jain, S., & Zimmerman, J. M. (2018) · HeartRhythm Case Reports · doi:10.1016/j.hrcr.2018.06.001
Hayes, D. L., Tabatabaei, N., Glikson, M., Asirvatham, S. J., & Friedman, P. A. (2012) · Wiley eBooks · doi:10.1002/9781118483923.ch13
Ablation of Persistent and Long-Standing Persistent Atrial Fibrillation
Montgomery, J. A., & Michaud, G. F. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-52992-1.00019-3
Licka, M., Jahn, L., Kelemen, K., Voss, F., Trappe, K., Becker, R., Bikou, O., Hauck, M., Koch, M., Katus, H. A., et al. (2011) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-011-0150-1
Swerdlow, C. D., Friedman, P. A., Asirvatham, S. J., & Hayes, D. L. (2021) · Wiley eBooks · doi:10.1002/9781119264002.ch10
Gillis, A. M. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-0285-9.00054-5
Clinical Role of Antiarrhythmic Drugs in the Prevention of Sudden Death
Lee, H.-C. (2008) · Springer eBooks · doi:10.1007/978-1-84628-854-8_53
Sugrue, A. M., Vaidya, V. R., Hayes, D. L., Glikson, M., Friedman, P. A., & Asirvatham, S. J. (2021) · Wiley eBooks · doi:10.1002/9781119264002.ch13
Paulin, F. L., & Exner, D. V. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1367-1.00081-1
SCHRICKEL, J. W., Beiert, T., & Andrié, R. (2024) · Elsevier eBooks · doi:10.1016/b978-3-437-21003-7.00013-3
Patients with a high defibrillation threshold: Approaches to management
Margenat, A. V., Zedan, A., Schubert, S. R., Gopani, S., & Hariharan, R. (2024) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14936
Ablation of Persistent and Long-Standing Persistent Atrial Fibrillation
Montgomery, J. A., Kowal, J. L., & Michaud, G. F. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-93110-6.00020-7
Defibrillation Threshold Testing After ICD Implantation in Patients with Chronic Kidney Disease
Timal, R. J., Osman, L., Rotmans, J. I., Bootsma, M., Mertens, B. J. A., Schalij, M. J., Rabelink, T. J., & Jukema, J. W. (2025) · Cardiology and Therapy · doi:10.1007/s40119-025-00403-x
Ablation ventrikulärer Tachykardien bei Herzinsuffizienz
Bänsch, D., Schneider, R., Akın, İ., & Nienaber, C. A. (2012) · Der Kardiologe · doi:10.1007/s12181-012-0407-x
体外式除細動不成功の高除細動閾値 (high DFT) 症例に対し冠静脈リード留置およびsotalolの併用で対処しえた特発性心室細動の1例
仲井, 盛., 深水, 誠., 小松, 宏., 北條, 林., 高野, 誠., 小田切, 史., 小宮山, 浩., 弓場, 隆., 辰本, 明., Mizusawa, Y., et al. (2009) · 心臓 · doi:10.11281/shinzo.41.s3_187
Obeidat, M., Al-Sheikhli, J., Blanks, A. M., Mayer, J. E., Lellouche, N., Dhanjal, T., & O’Shea, C. (2026) · The Journal of Physiology · doi:10.1113/jp290144
Moore, J. P., Mandapati, R., Shannon, K., Batra, A. S., & Balaji, S. (2013) · Springer eBooks · doi:10.1007/978-1-4471-4619-3_183
Implantierbare Kardioversions-Defibrillationsgeräte (ICD) – Von der Indikation zur Nachsorge
Bänsch, D. (2015) · Elsevier eBooks · doi:10.1016/b978-3-437-22107-1.50101-1
Metadata
- Authors
- Hohnloser, S. H., Dorian, P., Roberts, R., Gent, M., Israel, C. W., Fain, E., Champagne, J., & Connolly, S. J.
- Affiliations
- Goethe University Frankfurt (DE)
- ORCID
- Venue
- Circulation
- Published
- 2006-07-11
- Volume
- 114
- Issue
- 2
- Pages
- 104-109
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2026225505
- Cited by
- 179
- References
- 31
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 4 · 2023: 5 · 2022: 3 · 2021: 7 · 2020: 4 · 2019: 7 · 2018: 9 · 2017: 11 · 2016: 6 · 2015: 10 · 2014: 6 · 2013: 10 · 2012: 19
- FWCI
- 9.72
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation (publishedVersion)
- PubMed (publishedVersion)
- Funders
- McMaster University
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Keywords
- amiodarone, sotalol, implantable cardioverter-defibrillator, antiarrhythmic drugs, beta-blockers, defibrillation energy requirements, ICD shocks
- MeSH terms
- Carvedilol, Adrenergic beta-Antagonists, Aged, Amiodarone, Anti-Arrhythmia Agents, Atrial Fibrillation, Carbazoles, Combined Modality Therapy, Female, Heart Arrest, Humans, Male, Metoprolol, Middle Aged, Myocardial Infarction, Propanolamines, Sotalol, Ventricular Fibrillation, Ventricular Function, Left, Defibrillators, Implantable, Bisoprolol
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
